Brown Brothers Harriman & Co. Sells 2,670 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Brown Brothers Harriman & Co. trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 32.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,471 shares of the pharmacy operator’s stock after selling 2,670 shares during the quarter. Brown Brothers Harriman & Co.’s holdings in Walgreens Boots Alliance were worth $49,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Inlet Private Wealth LLC lifted its holdings in Walgreens Boots Alliance by 1.9% during the 2nd quarter. Inlet Private Wealth LLC now owns 47,820 shares of the pharmacy operator’s stock valued at $578,000 after buying an additional 900 shares in the last quarter. Capital Investment Counsel Inc boosted its holdings in shares of Walgreens Boots Alliance by 6.6% in the second quarter. Capital Investment Counsel Inc now owns 15,340 shares of the pharmacy operator’s stock valued at $186,000 after purchasing an additional 950 shares during the period. Continuum Advisory LLC grew its stake in Walgreens Boots Alliance by 71.2% in the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 1,020 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in Walgreens Boots Alliance by 1.6% during the 2nd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 65,690 shares of the pharmacy operator’s stock worth $795,000 after purchasing an additional 1,038 shares during the period. Finally, Sequoia Financial Advisors LLC raised its position in Walgreens Boots Alliance by 4.4% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock valued at $226,000 after purchasing an additional 1,063 shares in the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. Morgan Stanley cut their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research note on Friday, October 11th. Truist Financial reduced their price target on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a report on Monday, October 7th. Barclays increased their price objective on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. Bank of America reduced their price objective on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research note on Wednesday, September 4th. Finally, Evercore ISI increased their target price on Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a research report on Wednesday, October 16th. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus price target of $12.88.

Walgreens Boots Alliance Trading Up 3.8 %

Walgreens Boots Alliance stock opened at $9.06 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The stock has a market cap of $7.83 billion, a PE ratio of -0.91, a price-to-earnings-growth ratio of 1.14 and a beta of 0.69. The stock has a 50-day moving average of $9.14 and a two-hundred day moving average of $11.36. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, beating the consensus estimate of $0.36 by $0.03. The firm had revenue of $37.50 billion during the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. Walgreens Boots Alliance’s revenue was up 5.9% on a year-over-year basis. During the same period last year, the firm posted $0.67 EPS. On average, research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.04%. The ex-dividend date of this dividend is Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.